![](/img/cover-not-exists.png)
Safety and efficacy of a novel hepatobiliary MR contrast agent, Gd-DTPA-DeA: Results of phase I and phase II clinical trials
Akihiro Tanimoto, Masumi Kadoya, Yasutaka Kawamura, Ryohei Kuwatsuru, Takehiko Gokan, Shinji HirohashiVolume:
23
Year:
2006
Language:
english
Pages:
10
DOI:
10.1002/jmri.20543
File:
PDF, 536 KB
english, 2006